RxDoctor Payments Data

Kenneth Babe, MD

Allergy · Gallatin, TNNPI 1184617441

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $240 of the $274 with a category attached, or 87.6%. It is spread thinly across 9 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations.

$274in general payments, 2019–2025

Across 12 payments — averaging $22.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$57
  • Novartis$43
  • Amgen$34
  • ARS Pharmaceuticals Operations, Inc.$32
  • Takeda Pharmaceuticals U.S.A., Inc.$30
  • GSK$26
  • plus $53 from 3 others

What the payments were for

  • Food & beverage$24088%
  • Education$3412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few allergy providers in Tennesseeto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$21,719
Medicare patients
85
Services billed
876

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breo ElliptaFluticasone/Vilanterol29$14,830
Fluticasone-SalmeterolFluticasone Propion/Salmeterol35$10,029
Spiriva RespimatTiotropium Bromide14$9,168
Incruse ElliptaUmeclidinium Bromide11$6,202
BreynaBudesonide/Formoterol Fumarate18$3,426
Fluticasone Propionate133$2,844
Azelastine Hcl82$2,824
Wixela InhubFluticasone Propion/Salmeterol11$1,403
Albuterol Sulfate HfaAlbuterol Sulfate39$1,296
Ipratropium Bromide28$1,088
Montelukast Sodium84$964
Famotidine66$741
Omeprazole11$115
Prednisone45$101
Azithromycin20$84

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKBreo Ellipta, Incruse Ellipta$26$21,03240 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Tennesseeon file to place this against a meaningful peer group, so we don't.

Other allergy in Gallatin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →